Your browser doesn't support javascript.
loading
TEM-187, a new extended-spectrum ß-lactamase with weak activity in a Proteus mirabilis clinical strain.
Corvec, Stéphane; Beyrouthy, Racha; Crémet, Lise; Aubin, Guillaume Ghislain; Robin, Frédéric; Bonnet, Richard; Reynaud, Alain.
  • Corvec S; Service de Bactériologie-Hygiène, CHU de Nantes, Institut de Biologie, Nantes, France. stephane.corvec@chu-nantes.fr
Antimicrob Agents Chemother ; 57(5): 2410-2, 2013 May.
Article en En | MEDLINE | ID: mdl-23478954
ABSTRACT
A Proteus mirabilis clinical strain (7001324) was isolated from urine sample of a patient hospitalized in a long-term-care facility. PCR and cloning experiments performed with this strain identified a novel TEM-type ß-lactamase (TEM-187) differing by four amino acid substitutions (Leu21Phe, Arg164His, Ala184Val, and Thr265Met) from TEM-1. This characterization provides further evidence for the diversity of extended-spectrum ß-lactamases (ESBL) produced by P. mirabilis and for their potential spread to other Enterobacteriaceae due to a lack of sensitive detection methods used in daily practice.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteus mirabilis / Beta-Lactamasas / Farmacorresistencia Bacteriana Múltiple / Antibacterianos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2013 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteus mirabilis / Beta-Lactamasas / Farmacorresistencia Bacteriana Múltiple / Antibacterianos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2013 Tipo del documento: Article